Differential Alteration in Intestinal Epithelial Cell Expression of Toll-like Receptor 3 (TLR3) and TLR4 in Inflammatory Bowel Disease

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 2000 Nov 18

PMID 11083826

Citations 399

Authors

E Cario

D K Podolsky

Affiliations

Soon will be listed here.

Abstract

Initiation and perpetuation of the inflammatory intestinal responses in inflammatory bowel disease (IBD) may result from an exaggerated host defense reaction of the intestinal epithelium to endogenous lumenal bacterial flora. Intestinal epithelial cell lines constitutively express several functional Toll-like receptors (TLRs) which appear to be key regulators of the innate response system. The aim of this study was to characterize the expression pattern of TLR2, TLR3, TLR4, and TLR5 in primary intestinal epithelial cells from patients with IBD. Small intestinal and colonic biopsy specimens were collected from patients with IBD (Crohn's disease [CD], ulcerative colitis [UC]) and controls. Non-IBD specimens were assessed by immunofluorescence histochemistry using polyclonal antibodies specific for TLR2, TLR3, TLR4, and TLR5. Primary intestinal epithelial cells (IEC) of normal mucosa constitutively expressed TLR3 and TLR5, while TLR2 and TLR4 were only barely detectable. In active IBD, the expression of TLR3 and TLR4 was differentially modulated in the intestinal epithelium. TLR3 was significantly downregulated in IEC in active CD but not in UC. In contrast, TLR4 was strongly upregulated in both UC and CD. TLR2 and TLR5 expression remained unchanged in IBD. These data suggest that IBD may be associated with distinctive changes in selective TLR expression in the intestinal epithelium, implying that alterations in the innate response system may contribute to the pathogenesis of these disorders.

Citing Articles

The Pathogenesis of Inflammatory Bowel Diseases.

Chauhan G, Rieder F Surg Clin North Am. 2025; 105(2):201-215.

PMID: 40015812 PMC: 11868724. DOI: 10.1016/j.suc.2024.10.008.

Genome Sequencing and Assembly of Enterotoxigenic E9034A: Role of LngA, CstH, and FliC in Intestinal Cell Colonization and the Release of the Proinflammatory Cytokine IL-8.

Rodriguez-Martinez R, Ochoa S, Valle-Rios R, Jaimes-Ortega G, Hernandez-Castro R, Mancilla-Rojano J Microorganisms. 2025; 13(2).

PMID: 40005742 PMC: 11858209. DOI: 10.3390/microorganisms13020374.

De novo design of protein minibinder agonists of TLR3.

Adams C, Kim H, Burtner A, Lee D, Dobbins C, Criswell C Nat Commun. 2025; 16(1):1234.

PMID: 39890776 PMC: 11785957. DOI: 10.1038/s41467-025-56369-w.

Microbiome and Mucosal Immunity in the Intestinal Tract.

Ahrend H, Buchholtz A, Stope M In Vivo. 2024; 39(1):17-24.

PMID: 39740876 PMC: 11705094. DOI: 10.21873/invivo.13801.

Stage-specific expression of Toll-like receptors in the seminiferous epithelium of mouse testis.

Dogan G, Sandikci M, Karagenc L Histochem Cell Biol. 2024; 162(4):323-335.

PMID: 39085445 PMC: 11364606. DOI: 10.1007/s00418-024-02310-z.

References

Zhang F, Kirschning C, Mancinelli R, Xu X, Jin Y, Faure E . Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J Biol Chem. 1999; 274(12):7611-4. DOI: 10.1074/jbc.274.12.7611. View

Hampe J, Schreiber S, Shaw S, Lau K, Bridger S, Macpherson A . A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet. 1999; 64(3):808-16. PMC: 1377799. DOI: 10.1086/302294. View

Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y . Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol. 1999; 162(7):3749-52. View

Awane M, Andres P, Li D, Reinecker H . NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells. J Immunol. 1999; 162(9):5337-44. View

Ingalls R, Heine H, Lien E, Yoshimura A, Golenbock D . Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors. Infect Dis Clin North Am. 1999; 13(2):341-53, vii. DOI: 10.1016/s0891-5520(05)70078-7. View

Heine H, Kirschning C, Lien E, Monks B, Rothe M, Golenbock D . Cutting edge: cells that carry A null allele for toll-like receptor 2 are capable of responding to endotoxin. J Immunol. 1999; 162(12):6971-5. View

Yang R, Mark M, Gurney A, Godowski P . Signaling events induced by lipopolysaccharide-activated toll-like receptor 2. J Immunol. 1999; 163(2):639-43. View

Bhan A, Mizoguchi E, Smith R, Mizoguchi A . Colitis in transgenic and knockout animals as models of human inflammatory bowel disease. Immunol Rev. 1999; 169:195-207. DOI: 10.1111/j.1600-065x.1999.tb01316.x. View

Schultsz C, van den Berg F, ten Kate F, Tytgat G, Dankert J . The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology. 1999; 117(5):1089-97. DOI: 10.1016/s0016-5085(99)70393-8. View

10.

Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T . Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 1999; 11(4):443-51. DOI: 10.1016/s1074-7613(00)80119-3. View

11.

Lien E, Sellati T, Yoshimura A, Flo T, Rawadi G, Finberg R . Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem. 1999; 274(47):33419-25. DOI: 10.1074/jbc.274.47.33419. View

12.

Means T, Lien E, Yoshimura A, Wang S, Golenbock D, Fenton M . The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J Immunol. 1999; 163(12):6748-55. View

13.

Ohashi K, Burkart V, Flohe S, Kolb H . Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol. 2000; 164(2):558-61. DOI: 10.4049/jimmunol.164.2.558. View

14.

Cario E, ROSENBERG I, Brandwein S, Beck P, Reinecker H, Podolsky D . Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol. 2000; 164(2):966-72. DOI: 10.4049/jimmunol.164.2.966. View

15.

Kawasaki K, Akashi S, Shimazu R, Yoshida T, Miyake K, Nishijima M . Mouse toll-like receptor 4.MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol. J Biol Chem. 2000; 275(4):2251-4. DOI: 10.1074/jbc.275.4.2251. View

16.

Akashi S, Ogata H, Kirikae F, Kirikae T, Kawasaki K, Nishijima M . Regulatory roles for CD14 and phosphatidylinositol in the signaling via toll-like receptor 4-MD-2. Biochem Biophys Res Commun. 2000; 268(1):172-7. DOI: 10.1006/bbrc.2000.2089. View

17.

Beutler B . Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol. 2000; 12(1):20-6. DOI: 10.1016/s0952-7915(99)00046-1. View

18.

Poltorak A, Ricciardi-Castagnoli P, Citterio S, Beutler B . Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation. Proc Natl Acad Sci U S A. 2000; 97(5):2163-7. PMC: 15771. DOI: 10.1073/pnas.040565397. View

19.

Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M . Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol. 2000; 164(7):3476-9. DOI: 10.4049/jimmunol.164.7.3476. View

20.

Gatti E, Velleca M, Biedermann B, Ma W, Unternaehrer J, Ebersold M . Large-scale culture and selective maturation of human Langerhans cells from granulocyte colony-stimulating factor-mobilized CD34+ progenitors. J Immunol. 2000; 164(7):3600-7. DOI: 10.4049/jimmunol.164.7.3600. View